Welcome to Simcyp


population based pharmacokinetic modelling and simulation

home > research & development > publications > posters / abstracts


Posters / Abstracts

Simcyp Posters RSS

Please view our latest posters below:


  • Barter ZE et al.

    Oct 2006

    Prediction of the oral clearance of midazolam using in vitro data from recombinantly expressed enzymes and inter system extrapolation factors.
    14th North American ISSX Meeting
    Rio Grande, Puerto Rico, 22nd-26th October 2006

    Abstract published in:
    Drug Metabolism Reviews
    A71, 38(S2), 41, 2006

    Download poster

  • Almond LM et al.

    Oct 2006

    Prediction of the oral clearance of tolbutamimde in individuals with different CYP2C9 genotypes using in vitro enzyme kinetic data.
    14th North American ISSX Meeting
    Rio Grande, Puerto Rico, 22nd-26th October 2006

    Abstract published in:
    Drug Metabolism Reviews
    A323, 38(S2), 209-210, 2006

    Download poster

  • Almond LM et al.

    Sep 2006

    Utility of data from recombinant expressed genetic variants of CYPs in predicting the influence of genotype on in vivo drug kinetics - the case for S-Warfarin.
    35th ACCP Meeting
    Cambridge MA, USA, 17th-19th September 2006

    Abstract published in:
    Journal of Clinical Pharmacology
    A27, 46(9), 1067, 2006

    Download poster

  • Dickinson GL et al.

    Sep 2006

    Assessing the propagation of CYP2C9 polymorphism into the PK/PD of warfarin using clinical trial simulations (CTS).
    35th ACCP Meeting
    Cambridge MA, USA, 17th-19th September 2006

    Abstract published in:
    Journal of Clinical Pharmacology
    A28, 46(9), 1067, 2006

    Download poster

  • Johnson TN et al.

    Sep 2006

    Prediction of metabolic drug clearance in pediatric subjects and its sensitivity to different models for the development of CYP enzymes.
    35th ACCP Meeting
    Cambridge MA, USA, 17th-19th September 2006

    Abstract published in:
    Journal of Clinical Pharmacology
    A40, 46(9), 1070, 2006

    Download poster

  • Barter ZE et al.

    Sep 2006

    A meta-analysis of CYP3A4 abundance in human liver: use of different standards contributes to apparent heterogeneity in reported values.
    35th ACCP Meeting
    Cambridge MA, USA, 17th-19th September 2006

    Abstract published in:
    Journal of Clinical Pharmacology
    A82, 46(9), 1080, 2006

    Download poster

  • Ozdemir M et al.

    Sep 2006

    The impact of ketoconazole (KTZ) dosage regimen on midazolam clearance and its prediction using PBPK modelling.
    35th ACCP Meeting
    Cambridge MA, USA, 17th-19th September 2006

    Abstract published in:
    Journal of Clinical Pharmacology
    A18, 46(9), 1065, 2006

    Download poster

  • Rowland-Yeo K et al.

    Jun 2006

    Prediction of the inhibitory effects of ketaconazole and fluconazole on midazolam and zolpidem clearance from in vitro data using physiologically-based pharmacokinetic modelling.
    9th International Conference on Drug-Drug Interactions
    Seattle WA, USA, 20th-21st June 2006

    Download poster

  • Yang J et al.

    Jun 2006

    In-vitro stability of human recombinant cytochrome P450 enzymes.
    9th European ISSX Meeting
    Manchester, UK, 4th-7th June 2006

    Abstract published in:
    Drug Metabolism Reviews
    A135, 38(1), 102, 2006

    Download poster

  • Van LM et al.

    Jun 2006

    Estimation of the kinetic parameters of mechanism-based inhibition of CYP2D6 by methylenedioxymethamphetamine (MDMA) in cryopreserved human hepatocytes.
    9th European ISSX Meeting
    Manchester, UK, 4th-7th June 2006

    Abstract published in:
    Drug Metabolism Reviews
    A193, 38(1), 140-141, 2006

    Download poster

  • Van LM et al.

    Jun 2006

    Mechanism-based inactivation of CYP2D6 by methylenedioxymethamphetamine (MDMA): differences between expressed enzyme systems and human liver microsomes.
    9th European ISSX Meeting
    Manchester, UK, June 4th-7th June 2006

    Abstract published in:
    Drug Metabolism Reviews
    A54, 38(1), 45, 2006

    Download poster

  • Perrett HF et al.

    Jun 2006

    The use of recombinantly expressed standards for immuno-quantification of hepatic CYP3A5 can result in an underprediction of CYP3A5 abundance.
    9th European ISSX Meeting
    Manchester, UK, 4th-7th June 2006

    Abstract published in:
    Drug Metabolism Reviews
    A146, 38(1), 109, 2006

    Download poster

  • Johnson TN et al.

    Jun 2006

    Modelling of the age related changes of human CYP enzymes for predicting drug disposition in neonates, infants and children.
    9th European ISSX Meeting
    Manchester, UK, 4th-7th June 2006

    Abstract published in:
    Drug Metabolism Reviews
    A84, 38(1), 20-21, 2006

    Download poster

  • Jamei M et al.

    Jun 2006

    Co-operativity in the in vitro kinetics of cytochrome P450 (CYP) mediated drug metabolism will have minimal impact on in vivo metabolic clearance.
    9th European ISSX Meeting
    Manchester, UK, 4th-7th June 2006

    Abstract published in:
    Drug Metabolism Reviews
    A127, 38(1), 14, 2006

    Download poster

  • Heydari A et al.

    Jun 2006

    Predicting drug interactions with selective serotonin reuptake Inhibitors (SSRIs): impact of non-specific binding and active uptake.
    9th European ISSX Meeting
    Manchester, UK, 4th-7th June 2006

    Abstract published in:
    Drug Metabolism Reviews
    A100, 38(1), 79, 2006

    Download poster

  • Dickinson GL et al.

    Jun 2006

    The propagation of genetic polymorphism in CYP2C9 into tolbutamide pharmacokinetics: assessment using an intergrated model.
    9th European ISSX Meeting
    Manchester, UK, 4th-7th June 2006

    Abstract published in:
    Drug Metabolism Reviews
    A206, 38(1), 148, 2006

    Download poster

  • Turner DB et al.

    Jun 2006

    Prediction of non-specific hepatic microsomal binding from readily available physicochemical properties.
    9th European ISSX Meeting
    Manchester, UK, 4th-7th June 2006

    Abstract published in:
    Drug Metabolism Reviews
    A231, 38(1), 162, 2006

    Download poster

  • Ozdemir M et al.

    Jun 2006

    The impact of dose-staggering on the inhibitory effect of ketoconazole on midazolam clearance, and its prediction using physiologically-based pharmacokinetic modelling.
    9th European ISSX Meeting
    Manchester, UK, 4th-7th June 2006

    Abstract published in:
    Drug Metabolism Reviews
    A103, 38(1), 81, 2006

    Download poster

  • Barter ZE et al.

    Jun 2006

    Differences in cytochrome P450 (CYP3A4) expression alone do not explain inter-individual variability in CYP3A mediated hepatic testosterone 6ß hydroxylase (TST6ßOH) activity.
    9th European ISSX Meeting
    Manchester, UK, 4th-7th June 2006

    Abstract published in:
    Drug Metabolism Reviews
    A129, 38(1), 98, 2006

    Download poster

  • Almond LM et al.

    Jun 2006

    Prediction of the oral clearance of S-warfarin in CYP2C9 genotypes from in vitro enzyme kinetic data.
    9th European ISSX Meeting
    Manchester, UK, 4th-7th June 2006

    Abstract published in:
    Drug Metabolism Reviews
    A121, 38(1), 92-93, 2006

    Download poster

  • Barter ZE et al.

    Jan 2006

    Values of human hepatocellularity per gram of liver and associated variability for use in the prediction of human in vitro metabolic clearance.
    HUG Meeting
    Copenhagen, Denmark, 26th-27th January 2006

    Download poster

box top

Workshops


Please click here to view our upcoming workshops.
see more
Need more help?

Consortium members and associates include: